SCHEMBL9153045

SCHEMBL9153045

CCC(=O)C=[N+]=[N-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11082507 0.79
SCHEMBL23113780 0.74 FAAH (0.69)
SCHEMBL11252256 0.72 FAAH (0.53)
SCHEMBL7839616 0.72
SCHEMBL5204758 0.72 ALDH1A1 (0.38)
SCHEMBL17941109 0.72
SCHEMBL962322 0.71 GAA (0.54)
SCHEMBL9572473 0.70
SCHEMBL81647 0.70
Butane SCHEMBL11012887 0.70 FAAH (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250164511-A1 Diazobutanone Linker - Assisted High-Throughput Quantitative Analysis for Phosphate and Sulfate Containing Lipids WISCONSIN ALUMNI RESEARCH FOUNDATION 2025-05-22 US disclosed
US-20250164511-A1 Diazobutanone Linker - Assisted High-Throughput Quantitative Analysis for Phosphate and Sulfate Containing Lipids WISCONSIN ALUMNI RESEARCH FOUNDATION 2025-05-22 US disclosed
US-20240228488-A1 HETEROARYL INHIBITORS OF PLASMA KALLIKREIN TAKEDA PHARMACEUTICALS CO (JP) 2024-07-11 US disclosed
US-20240208985-A2 ANDROGEN RECEPTOR REGULATION BY SMALL MOLECULE ENANTIOMERS UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2024-06-27 US disclosed
CN-118059153-A Composition for improving acne skin 株式会社LG生活健康 2024-05-24 CN disclosed
US-20230133119-A1 ANDROGEN RECEPTOR REGULATION BY SMALL MOLECULE ENANTIOMERS UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2023-05-04 US disclosed
US-10392389-B2 Heterocyclic compounds for the inhibition of PASK BIOENERGENIX LLC (US) 2019-08-27 US disclosed
US-20150284395-A1 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK BIOENERGENIX LLC 2015-10-08 US disclosed
US-20150284395-A1 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK BIOENERGENIX LLC 2015-10-08 US disclosed
WO-2014066795-A1 HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK BIOENERGENIX (US) 2014-05-01 WO disclosed
US-8586550-B2 Thiazole derivatives as SGLT2 inhibitors and pharmaceutical composition comprising same GREEN CROSS CORPORATION (KR) 2013-11-19 US disclosed
US-20130090298-A1 Thiazole Derivatives as SGLT2 Inhibitors and Pharmaceutical Composition Comprising Same GREEN CROSS CORPORATION (KR) 2013-04-11 US disclosed
US-7423132-B2 Method for the enrichment and characterization of phosphorylated peptides or proteins BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2008-09-09 US disclosed
CN-1214717-A Coating composition comprising bicyclo- or spiro-orthoester-functional compound AKZO NOBEL NV (NL) 1999-04-21 CN disclosed
US-5389491-A Negative working resist composition MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 1995-02-14 US disclosed
EP-0095345-B1 TETRAHYDRO-3,5-DIOXO-1H-PYRROLIZINE-7A(5H)-CARBOXYLIC ACIDS AND DERIVATIVES AS COGNITION ACTIVATORS WARNER-LAMBERT COMPANY (US) 1988-04-13 EP disclosed
US-4607043-A SENILITY, AMNESIA WARNER-LAMBERT COMPANY (US) 1986-08-19 US disclosed
US-4547519-A Tetrahydro-3,5-dioxo-1H-pyrrolizine-7a(5H)-carboxylic acid and benzyl esters and amides thereof and their use in reversing amnesia WARNER-LAMBERT COMPANY (US) 1985-10-15 US disclosed
EP-0095345-A2 Tetrahydro-3,5-dioxo-1H-pyrrolizine-7a(5H)-carboxylic acids and derivatives as cognition activators WARNER-LAMBERT COMPANY (US) 1983-11-30 EP disclosed